Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Immuneering Corp (IMRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2023 |
4
| Brakewood Harold Eugene (Chief Business Officer) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 165,000 options
@ $9.71, valued at
$1.6M
|
|
| 12/27/2022 |
4
| Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp|
Txns:
| Exercised 2,500 options
@ $3.01, valued at
$7.5k
|
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Morales Mallory (VICE PRESIDENT, FINANCE) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 10,000 options
@ $6.33, valued at
$63.3k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2022 |
4
| Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp|
Txns:
| Exercised 2,000 options
@ $3.01, valued at
$6k
|
|
| 03/24/2022 |
4
| Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 3,000 shares
@ $8.02, valued at
$24.1k
|
|
| 03/23/2022 |
4
| Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 1,050 shares
@ $7.91, valued at
$8.3k
|
|
| 03/22/2022 |
4
| Barrett Scott (CHIEF MEDICAL OFFICER) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 900 shares
@ $7.485, valued at
$6.7k
|
|
| 03/16/2022 |
4
| Feinberg Peter (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 6,667 shares
@ $6.75, valued at
$45k
|
|
| 03/15/2022 |
4
| BERMAN ANN E (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 6,000 shares
@ $6.4, valued at
$38.4k
|
|
| 03/01/2022 |
4
| Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp|
Txns:
| Exercised 2,000 options
@ $3.01, valued at
$6k
|
|
| 02/14/2022 |
4
| Amin Biren (CFO, TREASURER) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 70,050 options
@ $9.66, valued at
$676.7k
|
|
| 02/14/2022 |
4
| Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 83,100 options
@ $9.66, valued at
$802.7k
|
|
| 02/14/2022 |
4
| Barrett Scott (CHIEF MEDICAL OFFICER) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 71,850 options
@ $9.66, valued at
$694.1k
|
|
| 02/14/2022 |
4
| Bookman Michael (GENERAL COUNSEL AND SECRETARY) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 47,300 options
@ $9.66, valued at
$456.9k
|
|
| 02/14/2022 |
4
| Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 156,485 options
@ $9.66, valued at
$1.5M
Granted 45,615 options
@ $10.63, valued at
$484.9k
|
|
| 01/18/2022 |
4
| HAUSMAN DIANA (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 25,200 options
@ $13, valued at
$327.6k
|
|
| 12/22/2021 |
4
| Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 322,691 shares
@ $0 |
|
| 09/21/2021 |
4
| Feinberg Peter (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 4,750 shares
@ $24.445, valued at
$116.1k
|
|
| 09/15/2021 |
4
| Feinberg Peter (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 5,750 shares
@ $21.5126, valued at
$123.7k
Bought 349 shares
@ $21.25, valued at
$7.4k
|
|
| 09/14/2021 |
4
| Zeskind Benjamin J. (PRESIDENT AND CEO) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 2,083 shares
@ $22.867, valued at
$47.6k
|
|
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Feinberg Peter (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Converted 133,572 shares
@ $0
Bought 129,167 shares
@ $15, valued at
$1.9M
Converted 123,155 shares
@ $0
Bought 129,167 shares
@ $15, valued at
$1.9M
Converted 82,108 shares
@ $0
Bought 33,333 shares
@ $15, valued at
$500k
Converted 102,926 preferred shares
@ $0
Converted 92,509 preferred shares
@ $0
Converted 51,462 preferred shares
@ $0
Converted 30,646 preferred shares
@ $0
Converted 30,646 preferred shares
@ $0 |
|
| 08/04/2021 |
4
| Zeskind Benjamin J. (President and CEO) has filed a Form 4 on Immuneering Corp|
Txns:
| Converted 49,099 shares
@ $0
Bought 2,098 shares
@ $15, valued at
$31.5k
Converted 40,928 preferred shares
@ $0
Converted 8,171 preferred shares
@ $0 |
|
| 08/04/2021 |
4
| KEATING LAURIE (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Bought 7,000 shares
@ $15, valued at
$105k
|
|
|
|
|